Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
James R. Bekeny, MD, is a vascular surgeon in the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart & Vascular Institute and director of the Cleveland Clinic Westlake Vein and Vascular Center. He is trained in vascular surgery and board certified in general surgery.
A Cleveland-area native, Dr. Bekeny earned his medical degree from Case Western Reserve School of Medicine. He completed his internship and residency in general surgery at University Hospitals of Cleveland and a fellowship in vascular surgery at Lutheran Medical Center, Cleveland.
Dr. Bekeny was appointed to the Cleveland Clinic staff in 2011. He previously was on the staff at Lakewood Hospital where he was chairman of the Department of Surgery for eight years and continues as medical staff president. His specialty interests in vascular surgery include carotid surgery, balloon angioplasty, aortic stent grafts, laser vein ablation and microphlebectomy. His general surgery specialties include hernia repair, laparoscopic gall bladder surgery, mole removal and thyroid, parathyroid and colon surgery.
Dr. Bekeny is a Fellow of the American College of Surgeons and a member of the American College of Phlebology (varicose and spider veins), the Cleveland Vascular Society, the Cleveland Surgical Society and the Northern Ohio Medical Association.
A resident of Westlake, Dr. Bekeny and his wife have a son who is an otolaryngology (ear, nose and throat) resident at Vanderbilt University Medical Center, Nashville, Tenn. and a daughter who is a general surgery resident at University Hospitals of Cleveland. In his leisure time, Dr. Bekeny enjoys skiing, gardening, woodworking and doing handyman projects.
Vascular surgery, veins, varicose veins, spider veins, venous disorders, vein ablation, sclerotherapy
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/27/2014, Dr. Bekeny has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.